Molecular and Cellular Biochemistry

, Volume 39, Issue 1, pp 261–279

The GABA postsynaptic membrane receptor-ionophore complex

Site of action of convulsant and anticonvulsant drugs
  • Richard W. Olsen
Article

Summary

The function of the inhibitory neurotransmitter, γ-aminobutyric acid (GABA), has been implicated in the mode of action of many drugs which excite or depress the central nervous system. Many convulsant agents appear to block GABA action whereas anticonvulsants enhance GABA action. Some of these drug effects involve altered GABA-mediated synaptic transmission at the level of GABA biosynthesis, release from nerve endings, uptake into cells, and metabolic degradation. A greater number of agents of diverse classes appear to affect GABA action at the postsynaptic membrane, as determined from both electrophysiological and biochemical studies. The recently developedin vitro radioactive receptor binding assays have led to a wealth of new information about GABA action and its alteration by drugs. GABA inhibitory transmission involves the regulation, by GABA binding to its receptor site, of chloride ion channels. In this GABA receptor-ionophore system, other drug receptor sites, one for benzodiazepines and one for barbiturates/picrotoxinin (and related agents) appear to form a multicomponent complex. In this complex, the drugs binding to any of the three receptor categories are visualized to have an effect on GABA-associated chloride channel regulation. Available evidence suggests that the complex mediates many of the actions of numerous excitatory and depressant drugs showing a variety of pharmacological effects.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Meldrum, B., 1979. In: GABA-Neurotransmitters (Krogsgaard-Larsen, P., Scheel-Kruger, J. & Kofod, H., eds.), pp. 390–405, Munksgaard, Copenhagen.Google Scholar
  2. 2.
    Olsen, R. W., Ticku, M. K., Greenlee, D. & Van Ness, P., 1979. In: GABA-Neurotransmitters (Krogsgaard-Larsen, P., Scheel-Kruger, J. & Kofod, H., eds.), pp. 165–178, Munksgaard, Copenhagen.Google Scholar
  3. 3.
    Enna, S. J. & Snyder, S. H., 1975. Brain Res. 100: 81–97.PubMedGoogle Scholar
  4. 4.
    Nistri, A., Constanti, A. & Krnjević, K., 1980. In: Receptors for Neurotransmitters and Peptide Hormones (Pepeu, G., Kuhar, M. J. & Enna, S. J., eds.), Adv. Biochem. Psychopharmacol. Vol. 21, pp. 81–90, Raven Press, New York.Google Scholar
  5. 5.
    Curtis, D. R., 1979. In: GABA-Neurotransmitters (Krogsgaard-Larsen, P., Scheel-Kruger, J. & Kofod, H., eds.) pp. 17–27, Munksgaard, Copenhagen.Google Scholar
  6. 6.
    McBurney, R. N. & Barker, J. L., 1978. Nature 274: 596–597.PubMedGoogle Scholar
  7. 7.
    Zukin, S. R., Young, A. B. & Snyder, S. H., 1974. Proc. Natl. Acad. Sci. USA 71: 4802–4807.PubMedGoogle Scholar
  8. 8.
    Greenlee, D. V., Van Ness, P. C. & Olsen, R. W., 1978. Life Sci. 22: 1653–1662.PubMedGoogle Scholar
  9. 9.
    Napias, C., Bergman, M. O., Van Ness, P. C., Greenlee, D. V. & Olsen, R. W., 1980. Life Sci. 27: 1001–1011.PubMedGoogle Scholar
  10. 10.
    Coyle, J. T. & Enna, S. J., 1976. Brain Res. 111: 119–133.PubMedGoogle Scholar
  11. 11.
    Olsen, R. W., Greenlee, D., Van Ness, P. & Ticku, M. K., 1978. In: Amino Acids as Chemical Transmitters (Fonnum, F., ed.), pp. 467–486, Plenum Press, New York.Google Scholar
  12. 12.
    Olsen, R. W. & Mikoshiba, K., 1978. J. Neurochem. 30: 1633–1636.PubMedGoogle Scholar
  13. 13.
    Greenlee, D. V., Van Ness, P. C. & Olsen, R. W., 1978. J. Neurochem. 31: 933–938.PubMedGoogle Scholar
  14. 14.
    Enna, S. J., Ferkany, J. W. & Krogsgaard-Larsen, P., 1979. In GABA-Neurotransmitters (Krogsgaard-Larsen, P., Scheel-Kruger, J. & Kofod, H., eds.) pp. 191–200, Munksgaard, Copenhagen.Google Scholar
  15. 15.
    Krogsgaard-Larsen, P., Hjeds, H., Curtis, D. R., Lodge, D. & Johnston, G. A. R., 1979. J. Neurochem. 32: 1717–1724.PubMedGoogle Scholar
  16. 16.
    Tallman, J. F., Paul, S. M., Skolnick, P. & Gallager, D. W., 1980. Science 207: 274–281.PubMedGoogle Scholar
  17. 17.
    Squires, R. F. & Braestrup, C., 1977. Nature 266: 732–734.PubMedGoogle Scholar
  18. 18.
    Möhler, H. & Okada, T., 1977. Science 198, 849–851.PubMedGoogle Scholar
  19. 19.
    Costa, T., Rodbard, D. & Pert, C. B., 1979. Nature 277: 315–317.PubMedGoogle Scholar
  20. 20.
    Haefely, W., Polc, P., Schaffner, R., Keller, H. H., Pieri, L. & Möhler, H., 1979. GABA-Neurotransmitters (Krogsgaard-Larsen, P., Scheel-Kruger, J. and Kofod, H., eds.) pp. 357–375, Munksgaard, Copenhagen.Google Scholar
  21. 21.
    Johnston, G. A. R., 1978. Ann. Rev. Pharmacol. Toxicol. 18: 269–289.Google Scholar
  22. 22.
    Olsen, R. W., Ticku, M. K., Van Ness, P. C. & Greenlee, D., 1978. Brain Res. 139, 277–294.PubMedGoogle Scholar
  23. 23.
    Olsen, R. W., Ticku, M. K. & Miller, T., 1978. Mol. Pharmacol. 14, 381–390.PubMedGoogle Scholar
  24. 24.
    Ticku, M. K. Ban, M. and Olsen, R. W., 1978. Mol. Pharmacol. 14: 391–402.PubMedGoogle Scholar
  25. 25.
    Ticku, M. K., Van Ness, P. C. Haycock, J. W., Levy, W. B. & Olsen, R. W., 1978. Brain Res 150: 642–647.PubMedGoogle Scholar
  26. 26.
    Leeb-Lundberg, F. & Olsen, R. W., 1980. In: Psychopharmacology and Biochemistry of Neurotransmitter Receptors (Yamamura, H. L, Olsen, R. W. & Usdin, E., eds.) pp. 593–606, Elsevier, New York.Google Scholar
  27. 27.
    Leeb-Lundberg, F., Napias, C. & Olsen, R. W., 1981. Brain Res., in the press.Google Scholar
  28. 28.
    Ticku, M. K. & Olsen, R. W., 1978. Life Sci. 22: 1643–1651.PubMedGoogle Scholar
  29. 29.
    Olsen, R. W., Leeb-Lundberg, F. & Napias, C., 1980. Brain Res. Bull. 5, Suppl. 2: 217–221.PubMedGoogle Scholar
  30. 30.
    Placheta, P. & Karobath, M., 1980. Eur. J. Pharmacol. 62: 225–228.PubMedGoogle Scholar
  31. 31.
    Olsen, R. W., Snowman, A. & Leeb-Lundberg, F., 1981. Fed. Proc. Abstracts, in press.Google Scholar
  32. 32.
    Johnston, G. A. R. & Willow, M., 1981. In: GABA and Benzodiazepine Receptors (Costa, E., DiChiara, G. & Gessa, G., eds.) Adv. Biochem. Psychopharmacol. Vol. 26, pp. 191–198, Raven Press, New York.Google Scholar
  33. 33.
    Beer, B., Klepner, C. A., Lippa A. S. & Squires, R. F., 1978. Pharmacol. Biochem. Behav. 9: 849–851.PubMedGoogle Scholar
  34. 34.
    Williams, M. & Risley, E. A., 1979. Life Sci. 24: 833–841.PubMedGoogle Scholar
  35. 35.
    O'Brien, R. A. & Spirt, N. M., 1980. Life Sci. 26: 1441–1445.PubMedGoogle Scholar
  36. 36.
    Leeb-Lundberg, F., Snowman, A. & Olson, R. W., 1980. Proc. Natl. Acad. Sci. USA, 77: 7468–7472.PubMedGoogle Scholar
  37. 37.
    Skolnick, P., Paul, S. & Barker, J. L., 1980. Eur. J. Pharmacol. 65, 125–127.PubMedGoogle Scholar
  38. 38.
    Sieghart, W., Placheta, P., Supavilai, P. & Karobath, M., 1981. In: GABA and Benzodiazepine Receptors (Costa, E., DiChiara, G. & Gessa, G., eds.) Adv. Biochem. Psychopharmacol. Vol. 26, pp. 121–128, Raven Press, New York.Google Scholar
  39. 39.
    Olsen, R. W. & Leeb-Lundberg, F., 1981. In: GABA and Benzodiazepine Receptors (Costa, E., DiChiara, G. & Gessa, G. eds.) Adv. Biochem. Psychopharmacol. Vol. 26, pp. 93–102, Raven Press, New York.Google Scholar
  40. 40.
    Supavilai, P. & Karobath, M., 1979. Eur. J. Pharmacol. 60, 111–113.PubMedGoogle Scholar
  41. 41.
    Tower, D. B., 1976. In: GABA in Nervous System Function (Roberts, E., Chase, T. N. & Tower, D. B., eds.) pp. 461–478, Raven Press, New York.Google Scholar
  42. 42.
    Horton, R. W., 1980. Br. Res. Bull. 5, Suppl. 2, pp. 605–608.Google Scholar
  43. 43.
    Ribak, C. E., Harris, A. B., Vaughn, J. E. & Roberts, E., 1979. Science 205, 211–214.PubMedGoogle Scholar
  44. 44.
    Barker, J. L., Nicoll, R. A. & Padjen, A., 1975. J. Physiol. 245: 521–548.PubMedGoogle Scholar
  45. 45.
    Macdonald, R. L. & Barker, J. L., 1978. Neurology (Minneapolis) 28: 325–330.Google Scholar
  46. 46.
    Straughan, D. W., 1974. Neuropharmacol. 13: 495–508.Google Scholar
  47. 47.
    Schlosser, W. & Franco, S., 1979. J. Pharmacol. Exp. Ther. 211: 290–295.PubMedGoogle Scholar
  48. 48.
    Geller, H. M., 1979. Neurosci. Lett. 15: 313–318.PubMedGoogle Scholar
  49. 49.
    Bowery, N. G., Collins, J. F. & Hill, R. G., 1976. Nature 261: 601–603.PubMedGoogle Scholar
  50. 50.
    Dray, A., 1975. Neuropharmacol. 14: 703–705.Google Scholar
  51. 51.
    Simmonds, M. A., 1980. Neuropharmacol. 19: 39–45.Google Scholar
  52. 52.
    Goldstein, D. B., 1973. J. Pharmacol. Exp. Thera. 168: 1–9.Google Scholar
  53. 53.
    Cooper, B. R., Viik, K., Ferris, R., & White, H. L., 1980. Br. Res. Bull. 5, Suppl. 2, pp. 815–820.Google Scholar
  54. 54.
    Straughan, D. W., 1978. Adv. Pharmacol. Thera. 2: 19–27.Google Scholar
  55. 55.
    Dray, A. & Bowery, N. G., 1979. In: GABA-Neurotransmitters (Krogsgaard-Larsen, P., Scheel-Kruger, J. & Kofod, H., eds.) pp. 376–389, Raven Press, New York.Google Scholar
  56. 56.
    Enna, S. J. & Maggi, A., 1979. Life Sci. 24: 1727–1738.PubMedGoogle Scholar
  57. 57.
    Bartholini, G., 1980. Br. Res. Bull. 5, Suppl. 2, pp. 487–490.Google Scholar
  58. 58.
    Lippa, A. S., Klepner, C. A., Benson, D. I., Critchett, D. J., Sano M. C. & Beer, B., 1980. Br. Res. Bull. 5 Suppl. 2, pp. 861–866.Google Scholar
  59. 59.
    Haefely, W. E., 1980. Br. Res. Bull. 5, Suppl. 2, pp. 873–878.Google Scholar
  60. 60.
    Macdonald, R. L. & Barker, J. L., 1979. Brain Res. 167: 323–326.PubMedGoogle Scholar
  61. 61.
    Loscher, W. & Frey, H. H., 1979. Naunyn. Schmiedebergs Arch. Pharmacol. 296: 263–269.Google Scholar
  62. 62.
    Metcalf, B. W., 1979. Biochem. Pharmacol. 28: 1705–1712.PubMedGoogle Scholar
  63. 63.
    Enna, S. J., Maggi, A., Worms, P. & Lloyd, K. G., 1980. Muscimol: Br. Res. Bull. 5, Suppl. 2, pp. 461–464.Google Scholar
  64. 64.
    Krogsgaard-Larsen, P., 1980. Mol. Cell. Biochem. 31: 105–121.PubMedGoogle Scholar
  65. 65.
    Meldrum, B., Pedley, T., Horton, R., Anlezark, G. & Franks, A., 1980. Br. Res. Bull. 5, Suppl. 2, pp. 685–690.Google Scholar
  66. 66.
    Frey, H.-H., Popp, C. & Loscher, W., 1979. Neuropharmacology 18: 581–590.PubMedGoogle Scholar
  67. 67.
    Fariello R, G, & Golden G. T., 1980. Br. Res. Bull. 5, Suppl. 2, pp. 691–700.Google Scholar
  68. 68.
    Krogsgaard-Larsen, P., Johnston, G. A. R., Lodge, D. & Curtis, D. R., 1977. Nature 268, 53–54.PubMedGoogle Scholar
  69. 69.
    Meldrum, B. & Horton, R., 1980. Eur. J. Pharmacol 61: 231–237.PubMedGoogle Scholar
  70. 70.
    Frey, H.-H. & Loscher, W., 1980. Neuropharmacol. 19: 217–220.Google Scholar
  71. 71.
    Morselli, P. L., Bossi, L., Henry, J. F., Zarifian, E. & Bartholini, G., 1980. Br. Res. Bull. 5, Suppl. 2, pp. 411–424.Google Scholar
  72. 72.
    Nicoll, R. A. & Wojtowicz, J. M., 1980. Brain Res. 191: 225–237.PubMedGoogle Scholar
  73. 73.
    Hochner, B., Spira, M. E. & Werman, R., 1976. Brain Res. 107: 85–103.PubMedGoogle Scholar
  74. 74.
    Dingledine, R. & Gjerstad, L., 1979. Brain Res. 168: 205–209.PubMedGoogle Scholar
  75. 75.
    Macdonald, R. L. & Barker, J. L., 1977. Nature 267: 720–721.PubMedGoogle Scholar
  76. 76.
    Nicoll, R. A. & Padjen, A., 1976. Neuropharmacol. 15: 69–71.Google Scholar
  77. 77.
    Scholfield, C. N., 1979. Br. J. Pharmacol. 67: 443P-444P.PubMedGoogle Scholar
  78. 78.
    Pellmar, T. C. & Wilson, W. A., 1977. Science 197: 912–913.PubMedGoogle Scholar
  79. 79.
    Downes, H. & Williams, J. K., 1969. J. Pharmacol. Exp. Thera. 168: 283–289.Google Scholar
  80. 80.
    Nestoros, J. N., 1980. Science 209: 708–710.PubMedGoogle Scholar
  81. 81.
    Macdonald, R. L. & Bergey, G. K., 1979. Brain Res. 170: 558–562.PubMedGoogle Scholar
  82. 82.
    Hayashi, T. & Negishi, K., 1979. Brain. Res. 175: 271–278.PubMedGoogle Scholar
  83. 83.
    Geller, H. M., Abstr. Soc. Neurosci. 6: 538 (1980) #184.5.Google Scholar
  84. 84.
    Raabe, W. & Ayala, G. F., 1976. Brain Res. 105: 597–601.PubMedGoogle Scholar
  85. 85.
    Ayala, G. F., Lin, S. & Johnston, D., 1977. Brain Res. 121: 245–258.PubMedGoogle Scholar
  86. 86.
    Deisz, R. A. & Lux, H. D., 1977. Neurosci. Lett. 5, 199–203.Google Scholar
  87. 87.
    Hershkowitz, N. & Ayala, G. F., 1980. Soc. Neurosci. Abstr. 6, 183 (#64.6).Google Scholar
  88. 88.
    Naik, S. R., Naid, P. R. & Sheth, U. K., 1978. Psychopharmacol. 57: 103–107.Google Scholar
  89. 89.
    Davidoff, R. A., J. c. Hackman & V. Grayson. Br. Res. Bull, 5, Suppl. 2, pp. 665–672.Google Scholar
  90. 90.
    Barker, J. L. & McBurney, R. N., 1979. Proc. R. Soc. Lond. 206: 319–327.Google Scholar
  91. 91.
    Ransom, B. R. & Barker, J. L., 1976. Brain Res. 114: 530–535.PubMedGoogle Scholar
  92. 92.
    Evans, R. H., 1979. Brain Res. 171: 113–120.PubMedGoogle Scholar
  93. 93.
    Schlosser, W. & Franco, S., 1980. Neuropharmacol. 18: 377–381.Google Scholar
  94. 94.
    Tsuchiya, T. & Fukushima, H., 1978. Eur. J. Pharmacol 48: 421–424.PubMedGoogle Scholar
  95. 95.
    Brown, D. A. & Constanti, A., 1978. Br. J. Pharmacol. 63: 217–224.PubMedGoogle Scholar
  96. 96.
    Curtis, D. R. & Lodge, D., 1977. Nature 270: 543–544.Google Scholar
  97. 97.
    Lebeda, F. J., Brown, T. H. & Johnston, D., 1980. Soc. Neurosci. Abstr. 6, 183 (#64.8).Google Scholar
  98. 98.
    Nicoll, R. A., Eccles, J. C., Oshima, T. C. & Rubia, F., 1975. Nature 258: 625–627.PubMedGoogle Scholar
  99. 99.
    Bowery, N. G. & Dray, A., 1978. Br. J. Pharmacol. 63: 179–215.Google Scholar
  100. 100.
    Richards, C. D., 1972. J. Physiol. 227: 749–767.PubMedGoogle Scholar
  101. 101.
    Fink, B. R. (ed.), 1980. Molecular Mechanisms of Anesthesia, Progress in Anesthesiology, Vol. 2, Raven Press, New York.Google Scholar
  102. 102.
    Collins, G. G., 1980. Brain Res. 290: 517–528.Google Scholar
  103. 103.
    Potashner, S. J., Lake, N., Langlois, E. A., Plouffe, L. & Lecavalier, D., 1980. Br. Res. Bull. 5, Suppl. 2, pp. 659–665.Google Scholar
  104. 104.
    Costa, E. & Guidotti, A., 1979. Ann. Rev. Pharmacol. Toxicol. 19: 531–545.Google Scholar
  105. 105.
    Sepinwall, J. & Cook, L., 1980. Br. Res. Bull. 5, Suppl. 2, pp. 839–848.Google Scholar
  106. 106.
    Waddington, J. L., 1978. Eur. J. Pharmacol. 51: 417–422.PubMedGoogle Scholar
  107. 107.
    Schmidt, R. F., Vogel, M. E., Zimmermann, M., 1967. Naunyn-Schmiedebergs Archives Pharmacol. 258: 69–82.Google Scholar
  108. 108.
    Dray, A. & Straughan, D. W., 1976. J. Pharm. Pharmacol. 28: 314–315.PubMedGoogle Scholar
  109. 109.
    Curtis, D. R., Lodge, D., Johnston, G. A. R. & Brand, S. J., 1976. Brain Res. 118: 344–347.PubMedGoogle Scholar
  110. 110.
    Raabe, W. & Gumnit, R. J., 1977. Epilepsia 18: 117–120.PubMedGoogle Scholar
  111. 111.
    Nistri, A. & Constanti, A., 1978. Neuropharmacol. 17: 127–135.Google Scholar
  112. 112.
    Simmonds, M. A., 1980. Nature 284: 558–560.PubMedGoogle Scholar
  113. 113.
    Polzin, R. L. & Barness, C. D., 1979. Neuropharmacol. 18: 431–434.Google Scholar
  114. 114.
    Okamoto, K. & Sakai Y., 1979. Br. J. Pharmacol. 65: 277–285.PubMedGoogle Scholar
  115. 115.
    Gallager, D. W., 1978. For. J. Pharmacol, 49: 133–143.Google Scholar
  116. 116.
    Zakusov, V. V., Ostrovskaya, R. U., Kozhechkin, S. N., Markovich, V. V., Molodavkin, G. M. & Voronina, T. A., 1977. Arch. Int. Pharmacodyn. Ther. 229: 313–326.PubMedGoogle Scholar
  117. 117.
    Geller, H. M., Hoffer, B. J. & Taylor, D. A., 1980. Fed. Proc. 39: 3016–3023.PubMedGoogle Scholar
  118. 118.
    Montarolo, P. G., Raschi, F. & Strata, P., 1979. Brain Res. 162: 358–362.PubMedGoogle Scholar
  119. 119.
    Macdonald, R. & Barker, J. L., 1978. Nature 271: 563–564.PubMedGoogle Scholar
  120. 120.
    Choi, D. W., Farb, D. H. & Fischbach, G. D., 1979. Nature 269: 342–344.Google Scholar
  121. 121.
    Olsen, R. W., Bergman, M. O., Van Ness, P. C., Lummis, S. C., Watkins, A. E., Napias, C. & Greenlee, D. V., 1981. Mol. Pharmacol. in the press.Google Scholar
  122. 122.
    Olsen, R. W., 1981. In: Psychopharmacology and Biochemistry of Neurotransmitter Receptors (Yamamura, H. I., Olsen, R. W. & Usdin, E., eds.) pp. 537–550, Elsevier, New York.Google Scholar
  123. 123.
    Lloyd, K. G. & Dreksler, S., 1978. In: Amino Acids as Chemical Transmitters (Fonnum, F., ed.) pp. 457–466, Plenum Press, New York.Google Scholar
  124. 124.
    Olsen, R. W., Van Ness, P. C., Napias, C., Bergman, M. & Tourtellotte, W. W., 1980. In: Receptors for Neurotransmitters and Peptide Hormones (Pepeu, G., Kuhar, M. J. & Enna, S. J., eds.) Adv. Biochem. Psychopharmacol. Vol. 21, pp. 451–460, Raven Press, New York.Google Scholar
  125. 125.
    Simantov, R., Oster-Granite, M. L., Herndon, R. M. & Snyder, S. H., 1976. Brain Res. 105, 365–371.PubMedGoogle Scholar
  126. 126.
    Campochiaro, R., Schwarcz, R. & Coyle, J. T., 1977. Brain Res. 136, 501–511.PubMedGoogle Scholar
  127. 127.
    Biggio, G., Corda, M. G., De Montis, G., Stefanini, E. & Gessa, G. L., 1980. Brain Res 193: 589–593.PubMedGoogle Scholar
  128. 128.
    Waddington, J. L. & Cross, A. J., 1980. Br. Res. Bull. 5, Suppl. 2, 825–828.Google Scholar
  129. 129.
    Guidotti, A., Gale, K., Suria, A. & Toffano, G., 1979. Brain Res. 172: 566–571.PubMedGoogle Scholar
  130. 130.
    Enna, S. J., Bennett, J. P., Bylund, D. B., Snyder, S. H., Bird, E. D. & Iversen, L. L., 1976. Brain Res. 116, 531–537.PubMedGoogle Scholar
  131. 131.
    Olsen, R. W., Reisine, T. D. & Yamamura, H. I., 1980. Life Sci. 27, 801–808.PubMedGoogle Scholar
  132. 132.
    Beaumont, K., Chilton, W., Yamamura, H. I. & Enna, S. J., 1978. Brain Res. 148: 153–162.PubMedGoogle Scholar
  133. 133.
    Morin, A. M. & Wasterlain, C., 1980. Life Sci. 26: 1239–1245.PubMedGoogle Scholar
  134. 134.
    Krogsgaard-Larsen, P., Snowman, A., Lummis, S. C. & Olsen, R. W., 1981. J. Neurochem, in the press.Google Scholar
  135. 135.
    Mohler, H. & Okada, T., 1977. Nature 267: 65–67.Google Scholar
  136. 136.
    Enna, S. J. & Snyder, S. H., 1977. Mol. Pharmacol. 13: 442–453.PubMedGoogle Scholar
  137. 137.
    Wong, D. T., Bymaster, F. P. & Lane, P. T., 1980. Br. Res. Bull. 5, Suppl. 2, pp. 853–856.Google Scholar
  138. 138.
    Toffano, G., Guidotti, A. & Costa, E., 1978. Proc. Natl. Acad. Sci. USA 75, 4024–4028.PubMedGoogle Scholar
  139. 139.
    Johnston, G. A. R. & Kennedy, S. M. E., 1978. In: Amino Acids as Chemical Transmitters (Fonnum, F., ed.) pp. 507–516, Plenum Press, New York.Google Scholar
  140. 140.
    Yoneda, Y. & Kuriyama, K., 1980. Nature 285: 670–673.PubMedGoogle Scholar
  141. 141.
    Young, A. B. & Snyder, S. H., 1974. Proc. Nat. Acad. Sci. USA 71: 4002–4005.PubMedGoogle Scholar
  142. 142.
    Goldinger, A. & Müller, W. E., 1980. Neurosci. Lett 16: 91–95.PubMedGoogle Scholar
  143. 143.
    Takeuchi, A. & Takeuchi, N., 1969. J. Physiol. 205: 377–391.PubMedGoogle Scholar
  144. 144.
    Ticku, M. K. & Olsen, R. W., 1977. Biochim. Biophys. Acta 464: 519–529.PubMedGoogle Scholar
  145. 145.
    Ticku, M. K. & Olsen, R. W., 1979. Neuropharmacol. 18: 315–318.Google Scholar
  146. 146.
    Leeb-Lundberg, F., Snowman, A. & Olsen, R. W., 1981. Fed. Proc. Abstracts, in the press.Google Scholar
  147. 147.
    Randall, L. O., Schallek, W., Sternbach, L. H. & Ning, R. Y., 1974. In: Psychopharmacology Agents III (Gordon, M., ed) pp. 175–281, Academic Press, New York.Google Scholar
  148. 148.
    Paul, S. M., Syapin, P. J., Paugh, B. A., Moncada, A. & Skolnick, P., 1979. Nature 281: 688–689.PubMedGoogle Scholar
  149. 149.
    Mazière, M., Godot, J. M., Berger, G., Baron, J. C., Comar, D., Cepeda, C., Menini, C. & Nauquet, R., 1981. In: GABA and Benzodiazepine Receptors (Costa, E., DiChiara, G. & Gessa, G., eds.) Adv. in Biochem. Psychopharmacol. Vol. 26, pp. 273–286, Raven Press, New York.Google Scholar
  150. 150.
    Duka, T., Hollt, V. & Herz, A., 1979. Brain Res. 179: 147–156.PubMedGoogle Scholar
  151. 151.
    Young, W. S. & Kuhar, M. J., 1979. Nature 280, 393–395.Google Scholar
  152. 152.
    Shibuya, H., Gale, K. & Pert, C. B., 1980. Eur. J. Pharmacol. 62: 243–244.PubMedGoogle Scholar
  153. 153.
    Chang, R. S., Tran, V. T. & Snyder, S. H., 1980. Brain Res. 190: 95–110.PubMedGoogle Scholar
  154. 154.
    Biggio, G., Corda, M. G., Lamberti, C. & Gessa, G. L., 1979. Eur. J. Pharmacol. 58: 215–216.PubMedGoogle Scholar
  155. 155.
    Möhler, H., Okada, T. & Enna, S.J., 1978. Brain Res. 156: 391–395.PubMedGoogle Scholar
  156. 156.
    Gallager, D. W., Thomas, J. W. & Tallman, J. F., 1978. Biochem. Pharmacol. 27: 2745–2749.PubMedGoogle Scholar
  157. 157.
    Gallager, D. W., Mallorga, P. & Tallman, J. F., 1980. Brain Res. 180: 209–220.Google Scholar
  158. 158.
    Speth, R. C., Bresolin, N., Mimaki, T., Deshmukh, P. P. & Yamamura, H. I., 1981. In: GABA and Benzodiazepine Receptors (Costa, E., DiChiara, G. & Gessa, G., eds.) Adv. in Biochem. Psychopharmacol. Vol. 26, pp. 27–39, Raven Press, New York.Google Scholar
  159. 159.
    Paul, S. M. & Skolnick, P., 1978. Science 202: 892–894.PubMedGoogle Scholar
  160. 160.
    McNamara, J. O., Peper, A. M. & Patrone, V., 1980. Proc. Natl. Acad. Sci. USA 77: 3029–3032.PubMedGoogle Scholar
  161. 161.
    Nestoros, J. N., 1980. Br. Res. Bull. 5, Suppl. 2, pp. 849–852.Google Scholar
  162. 162.
    Möhler, H., Battersby, M. K. & Richards, J. G., 1980. Proc. Natl. Acad. Sci. USA 77: 1666–1670.PubMedGoogle Scholar
  163. 163.
    Placheta, P. & Karobath, M., 1979. Brain Res. 178: 580–583.PubMedGoogle Scholar
  164. 164.
    Wastek, G. J., Speth, R. C., Reisine, T. D. & Yamamura, H. I., 1978. Eur. J. Pharmacol. 50: 445–447.PubMedGoogle Scholar
  165. 165.
    Sieghart, W. & Karobath, M., 1980. Nature 286, 285–287.PubMedGoogle Scholar
  166. 166.
    Squires, R. F., Benson, D. I., Braestrup, C., Coupet, J. Klepner, C. A., Myers, V. & Beer, B., 1979. Pharmacol. Biochem. Behav. 10: 825–830.PubMedGoogle Scholar
  167. 167.
    Marangos, P. J., Paul, S. M., Parma, A. M., Goodwin, F. K., Syapin, P. & Skolnick, P., 1979. Life Sci. 24: 851–858.PubMedGoogle Scholar
  168. 168.
    Snyder, S. H. & Childers, S. R., 1979. Ann. Rev. Neurosci. 2: 35–64.PubMedGoogle Scholar
  169. 169.
    Asano, T. & Spector, S., 1979. Proc. Natl. Acad. Sci. USA 76: 977–981.PubMedGoogle Scholar
  170. 170.
    Davies, L. P., Cook, A. F., Poonian, M. & Taylor, K. M., 1980. Life Sci. 26: 1089–1095.PubMedGoogle Scholar
  171. 171.
    Möhler, H., Polc, P., Cumin, R., Pieri, L. & Kettler, R., 1979. Nature 278: 563–565.PubMedGoogle Scholar
  172. 172.
    Olsen, R. W. & Leeb-Lundberg, F., 1980. Eur. J. Pharmacol. 65: 101–104.PubMedGoogle Scholar
  173. 173.
    Braestrup, C., Nielsen, M. & Olsen, C. E., 1980. Proc. Natl. Acad. Sci. USA 77: 2288–2292.PubMedGoogle Scholar
  174. 174.
    Davis, L. G. & Cohen, R. K., 1980. Biochem. Biophys. Res. Comm. 92: 141–148.PubMedGoogle Scholar
  175. 175.
    Araki, T., Ito, M. & Oscarsson, O., 1961. J. Physiol. 159: 410–435.PubMedGoogle Scholar
  176. 176.
    Martin, I. L. & Candy, J. M., 1980. Neuropharmacol. 19: 175–179.Google Scholar
  177. 177.
    Tallman, J. F., Thomas, J. W. & Gallager, D. W., 1978. Nature 274: 383–385.PubMedGoogle Scholar
  178. 178.
    Karobath, M. & Sperk, G., 1979. Proc. Natl. Acad. Sci. USA 76: 1004–1006.PubMedGoogle Scholar
  179. 179.
    Briley, M. S. & Langer, S. Z., 1978. Eur. J. Pharmacol. 52: 129–132.PubMedGoogle Scholar
  180. 180.
    Chiu, T. H. & Rosenberg, H. C., 1979. Eur. J. Pharmacol. 56: 337–345.PubMedGoogle Scholar
  181. 181.
    Dudai, Y., 1979. Brain Res. 167: 422–425.PubMedGoogle Scholar
  182. 182.
    Squires, R. F., 1981. In: GABA and Benzodiazepine Receptors (Costa, E., DiChiara, G. & Gessa, G., eds.) Adv. Biochem. Psychopharmacol. Vol. 26, pp. 129–138, Raven Press, New York.Google Scholar
  183. 183.
    Maurer, R., 1979. Neurosci. Lett. 12: 65–68.PubMedGoogle Scholar
  184. 184.
    Karobath, M., Placheta, P., Lippitsch, M. & Krogsgaard-Larsen, P., 1979. Nature 278: 748–749.PubMedGoogle Scholar
  185. 185.
    Braestrup, C., Nielsen, M., Krogsgaard-Larsen, P. & Falch, E., 1979. Nature 280: 331–333.PubMedGoogle Scholar
  186. 186.
    Karobath, M. & Lippitsch, M., 1979. Eur. J. Pharmacol. 58: 485–488.PubMedGoogle Scholar
  187. 187.
    Barker, J. L. & Mathers, D. A., 1980. Soc. Neurosci. Abstr. 6, 189 (#67.2).Google Scholar
  188. 188.
    Supavilai, P. & Karobath, M., 1980. Neurosci. Lett. 19: 337–341.PubMedGoogle Scholar
  189. 189.
    Guidotti, A., Toffano, G., Baraldi, M., Schwartz, J. P. & Costa, E., 1979. In: GABA-Neurotransmitters (Krogsgaard-Larsen, P., Scheel-Kruger, J. & Kofod, H., eds.) pp. 406–415, Munksgaard, Copenhagen.Google Scholar
  190. 190.
    Massotti, M., Guidotti, A. & Costa, E., 1981. In: GABA and Benzodiazepine Receptors (Costa, E., DiChiara, G. & Gessa, G., eds.) Adv. Biochem. Psychopharmacol. Vol. 26, pp. 19–26, Raven Press, New York.Google Scholar
  191. 191.
    Meiners, B. A. & Salama, A. I., 1980. Soc. Neurosci. Abstr. 6, 189 (#467.4).Google Scholar
  192. 192.
    Gavish, M. & Snyder, S. H., 1980. Nature 287: 651–652.PubMedGoogle Scholar
  193. 193.
    Gavish, M. & Snyder, S. H., 1980. Life Sci. 26: 579–582.PubMedGoogle Scholar
  194. 194.
    Sherman-Gold, R. & Dudai, Y., 1980. Brain Res. 198: 485–490.PubMedGoogle Scholar
  195. 195.
    Fong, J. & Goldstein, M., 1980. Soc. Neurosci. Abstr. 6, 255 (#94.13).Google Scholar
  196. 196.
    Asano, T. & Ogasawara, N., 1980. Life Sci. 26: 607–613.PubMedGoogle Scholar
  197. 197.
    Asano, T. & Ogasawara, N., 1980. Life Sci. 26: 1131–1137.PubMedGoogle Scholar
  198. 198.
    Gavish, M. & Snyder, S. H., 1980. Soc. Neurosci. Abstr. 6, 236 (#89.2).Google Scholar
  199. 199.
    Yousufi, M. A. K., Thomas, J. W. & Tallman, J. F., 1979. Life Sci. 25: 463–470.PubMedGoogle Scholar
  200. 200.
    Lang, B., Barnard, E. A., Chang, L. R. & Dolly, J. O., 1979. FEBS Lett. 104: 149–153.PubMedGoogle Scholar
  201. 201.
    Bymaster, F. P. & Wong, D. T., 1980. Soc. Neurosci. Abstr. 6, 252 (#94.3).Google Scholar
  202. 202.
    Chiu, T. H. & Rosenberg, H. C., 1980. Fed. Proc. 39, 1006 (Abstr. #3889).Google Scholar
  203. 203.
    Greenlee, D. V. & Olsen, R. W., 1979. Biochem. Biophys, Res. Comm. 88: 380–387.Google Scholar
  204. 204.
    Butler, T. C., 1942. J. Pharmacol. 74: 118–128.Google Scholar
  205. 205.
    Burch, T. & Ticku, M. K., 1980. Eur. J. Pharmacol. 67: 325–326.PubMedGoogle Scholar
  206. 206.
    Huang, L.-Y. and Barker, J. L., 1980. Science 207: 195–197.PubMedGoogle Scholar
  207. 207.
    Supavilai, P. & Karobath, M., 1980. Ent. J. Pharmacol. 62: 229–233.Google Scholar
  208. 208.
    Karobath, M., Drexler, G. & Supavilai, P., 1981. Life Sci. 28: 307–313.PubMedGoogle Scholar
  209. 209.
    Waddington, J. L. & Cross, A. J., 1980. Br. Res. Bull. 5, Suppl. 2: 503–505.Google Scholar
  210. 210.
    Bowery, N. G., Hill, D. R., Hudson, A. L., Doble, A., Middlemiss, D. N., Shaw, J. & Turnbull, M., 1980. Nature 283: 92–94.PubMedGoogle Scholar
  211. 211.
    Skolnick, P., Syapin, P. J., Paugh, B. A., Moncada, V., Marangos, P. J. & Paul, S. M., (1979) Proc. Natl. Acad. Sci. USA 76: 1515–1518.PubMedGoogle Scholar
  212. 212.
    Ticku, M. K., 1980. Brain Res. Bull. 5: 919–923.Google Scholar
  213. 213.
    Tenen, S. S. & Hirsch, J. D., 1980. Nature 288, 609–610.PubMedGoogle Scholar
  214. 214.
    Ticku, M. K. & Burch, T., 1980. Biochem. Pharmacol. 29: 1217–1220.PubMedGoogle Scholar

Copyright information

© Martinus Nijhoff/Dr W. Junk Publishers 1981

Authors and Affiliations

  • Richard W. Olsen
    • 1
  1. 1.Division of Biomedical Sciences and Dept. of BiochemistryUniv. of CaliforniaRiversideUSA

Personalised recommendations